0 NASDAQ Companies - May 21, 2024Alpha Tau to Present at the Jefferies Global Healthcare ConferenceJERUSALEM, May 21, 2024 (GLOBE NEWSWIRE) — Alpha Tau Medical Ltd. (“Alpha Tau”, or the “Company”) (NASDAQ: DRTS, DRTSW), the […]Read More
0 NASDAQ Companies - May 21, 2024Centessa Pharmaceuticals to Participate in Upcoming Investor ConferencesBOSTON and LONDON, May 21, 2024 (GLOBE NEWSWIRE) — Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company that aims […]Read More
0 NASDAQ Companies - May 21, 2024Silo Pharma Announces Positive Results from Study for Depression Treatment, Remission, and Relapse PreventionThe study has identified a potentially new drug formulation that could potentially extend the period of remission and prevent relapse […]Read More
0 NASDAQ Companies - May 21, 2024GRI Bio Presents Positive Preclinical Data from Pipeline of NKT Cell Modulators in Development for the Treatment of Systemic Lupus Erythematosus (SLE)Data presented at the 14thInternational Congress on Autoimmunity Encouraging preclinical data observed to date on par with OFEV®(nintedanib),a leading tyrosine […]Read More
0 NASDAQ Companies - May 21, 2024Alliance Entertainment’s Distribution Solutions Extends Partnership with Cineverse PLANTATION, Fla. and LOS ANGELES, May 21, 2024 (GLOBE NEWSWIRE) — Distribution Solutions, a division of Alliance Entertainment (NASDAQ: AENT), […]Read More
0 NASDAQ Companies - May 21, 2024Earlyworks Co., Ltd., a blockchain technology provider, forms business alliance with Relic, a business co-creation companyTOKYO, May 21, 2024 (GLOBE NEWSWIRE) — Earlyworks Co., Ltd. (Nasdaq: ELWS) (the “Company” or “Earlyworks”) (Head office: Taito-ku, Tokyo; CEO: […]Read More
0 NASDAQ Companies - May 21, 2024Positive Statistically Significant Phase 2 Clinical Trial Results of Biodexa’s Newly-licensed eRapa™ in Familial Adenomatous Polyposis (FAP) Scheduled for Presentation at the 2024 Digestive Disease Week Annual MeetingMay 21, 2024 Biodexa Pharmaceuticals PLC(“Biodexa” or the “Company”) Positive Statistically Significant Phase 2 Clinical Trial Results of Biodexa’s Newly-licensed […]Read More
0 NASDAQ Companies - May 21, 2024Palisade Bio’s Lead Product Candidate, PALI-2108 Demonstrates Local Bioactivation and Dose Dependent Efficacy Response in Preclinical Mouse ModelsData presented at Digestive Disease Week (DDW) 2024 Preclinical data demonstrate PALI-2108 to be safe, effective, and well tolerated PALI-2108 […]Read More
0 NASDAQ Companies - May 21, 2024PodcastOne’s (Nasdaq: PODC) LADYGANG Podcast Presents the “You Never Forget Your First” Tour Presented by CLEARSTEMLOS ANGELES, May 21, 2024 (GLOBE NEWSWIRE) — PodcastOne (NASDAQ: PODC), a leading podcast platform and a subsidiary of LiveOne […]Read More
0 NASDAQ Companies - May 21, 2024Moblico Partners with Bridgeline to Present at Applied AI Conference in ChicagoWOBURN, Mass., May 21, 2024 (GLOBE NEWSWIRE) — Bridgeline Digital, Inc. (NASDAQ: BLIN), a global leader in AI-powered marketing technology, […]Read More